Evaluation of muscle relaxant reversal during general anesthesia emergence with SGD

Evaluation of muscle relaxant reversal during general anesthesia emergence with SGD - evaluation of muscle relaxant reversal timing

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016419

Enrollment

Registered

2015-02-03

Start date

2015-02-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who undergo general anesthesia with SGD

Interventions

Muscle reversal before sevflurane attenuation Muscle reversal after sevoflurane attenuation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo general anesthesia

Exclusion criteria

Exclusion criteria: Emergency Patients Patients who are not appropriate for SGD.

Design outcomes

Primary

Measure	Time frame
Basic factors and ventiation troubles	—

Secondary

Measure	Time frame
Depth of anesthesia incidence of laryngospasm	—

Countries

Japan

Contacts

Public ContactKomasawa Nobuyasu

Osaka Medical College Department of Anesthesiology

koma21century@yahoo.co.jp0726-84-6361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026